WHAT DOCTORS READ:HIB VACCINE: POOR SHOWING

A major study examining two versions of the new haemophilus influenzae b (Hib) vaccine, introduced this month in Britain, shows that they don’t work as well as they should.


The vaccine, being offered to infants at two, three and four months, is supposed to protect against Hib caused meningitis.


However, the study by the National Centers for Disease Control in Atlanta, Georgia, of 10,400,000 children, showed that the “polysaccharide” version of the vaccine offered protection in 64 per cent of cases and the new “conjugate” vaccine, only 74 per cent protection.


Nine of 75 children with Hib disease had received the vaccine just two weeks before they became ill.


Originally developed to stop a host from rejecting an organ transplant, the drug is now being used for all manner of autoimmune illness.


The New England Journal of Medicine, 18 June 1992.

What Doctors Don't Tell You Written by What Doctors Don't Tell You

We Humbly Recommend

Get the Healthiest Newsletter!

Get a dose of Healthy delivered straight to your inbox. Each FREE issue features amazing content that will elevate your Body, Mind, and Spirit.

Your data is never shared with 3rd parties

Introducing

Healthy Shopping

Health and Wellbeing products lovingly curated for you.